Tempus Data, Analytics & Interoperability: Features, Pricing & Alternatives

Precision medicine and genomic testing platform

Data, Analytics & Interoperability Cloud

Tempus is a precision medicine company that combines genomic testing and clinical data with AI to help physicians make treatment decisions. It also provides de-identified data and analytics to life sciences researchers and operates clinical labs across the United States.

  • Founded: 2015
  • HQ: Chicago, IL
  • Best for: Oncology practices, health systems, and life sciences researchers seeking genomic testing and AI-driven precision medicine tools.
  • Our take

    Tempus is best suited for Oncology practices, health systems, and life sciences researchers seeking genomic testing and AI-driven precision medicine tools.. Combines genomic testing with AI-driven clinical decision support..

    Main limitation: pricing is not publicly disclosed and requires contacting the vendor.. Scored 3.3/5 across the EHRAtlas scorecard.

    Tempus Overview

    Tempus is a healthcare technology company focused on precision medicine. It provides genomic sequencing and molecular testing services, along with a clinical platform that helps physicians access patient information, place orders, track progress, and review summarized results and therapy updates. The platform is designed to integrate with electronic health records (EHRs) and includes an AI-enabled clinical assistant.

    Beyond clinical care, Tempus aggregates and de-identifies patient data to support research. The company states that it employs de-identification methods, including HIPAA Safe Harbor and Expert Determination, to create datasets for life sciences companies and researchers. This data is used to develop genomic models, identify patterns in disease, and support clinical trials.

    Tempus operates multiple laboratories and offices across the United States and internationally, with headquarters in Chicago. Its leadership team includes experts in data science, computational biology, and oncology. The company has announced initiatives such as building a multimodal whole-genome dataset and deploying autonomous AI in cardiology with ARPA-H funding.

    Tempus Evaluation

    Scored against the same 7 dimensions used in the EHRAtlas Scorecard. 0 = not enough public information to score. These are analyst estimates, not endorsements — verify during a demo. Buyers should validate capabilities, pricing, implementation requirements, and fit during vendor evaluation.

    Product Maturity 4/5

    Age, customer base, feature depth.

    Tempus is a precision medicine company with multiple labs, international presence, and a product portfolio, though exact customer counts are not provided.

    Target Market 4/5

    Solo/small, mid, enterprise, or niche.

    The platform targets enterprise healthcare providers, oncology practices, and life sciences researchers rather than small independent practices.

    Key Differentiators 5/5

    What sets it apart from alternatives.

    Key differentiators include the integration of genomic testing with AI-driven clinical decision support and a de-identified multimodal dataset for research.

    Integrations 3/5

    Systems it connects to out of the box.

    The platform states it securely accesses patient information across EHRs, but specific integration partners or APIs are not detailed on the provided pages.

    Compliance & Certifications 4/5

    HIPAA, SOC 2, ONC, FDA, other.

    Tempus emphasizes HIPAA compliance and de-identification standards, and its information security policy references HIPAA, HITECH, and GINA, but no specific certifications like SOC 2 are mentioned.

    Support Model 3/5

    In-house vs outsourced, SLAs, channels.

    Customer service is available via phone and fax during business hours, but details on SLAs or dedicated support tiers are not provided.

    Pricing Model 0/5

    How it charges and what the entry point is.

    No pricing information is available on the provided pages; pricing requires contacting the vendor.

    Tempus Pricing

    Practice SizeMonthly (per provider)ImplementationNotes
    Enterprise Contact vendor Contact vendor Pricing is not publicly disclosed and depends on the scope of genomic testing and platform access.

    Pricing is indicative. Always request a formal quote and ask about module, interface, and annual maintenance fees.

    Key Features

    Genomic Testing

    Provides molecular profiling and sequencing services to guide precision treatment decisions.

    AI-Enabled Clinical Assistant

    Offers a platform that helps physicians access patient information and review summarized results.

    EHR Integration

    Securely accesses patient information across desktop, mobile, and EHR systems.

    De-Identified Data for Research

    Aggregates and de-identifies patient data to support life sciences research and clinical trials.

    Order and Results Tracking

    Allows providers to place orders, track progress, and receive automatic therapy updates.

    Fit

    Specialties Served

    Integrations & Compliance

    Capabilities

    genomicTesting aiClinicalAssistant ehrIntegration deIdentifiedData clinicalDecisionSupport

    Systems It Connects To

    Compliance

    ItemStatusNote
    ONC Certified Health IT No Not listed in the ONC CHPL active database.
    HIPAA Yes Tempus states it is subject to HIPAA and employs de-identification methods that meet or exceed HIPAA standards.
    SOC 2 Not published No mention of SOC 2 certification on the provided pages.
    FDA Not published No FDA clearances or approvals are mentioned on the provided pages.

    Tempus Pros & Cons

    Pros

    • Combines genomic testing with AI-driven clinical decision support.
    • Offers a de-identified multimodal dataset for research.
    • Integrates with EHRs for clinical workflows.
    • Operates multiple labs and has a global presence.
    • Leadership includes experts in oncology, data science, and computational biology.

    Cons

    • Pricing is not publicly disclosed and requires contacting the vendor.
    • Limited information on specific EHR integrations and APIs.
    • No mention of ONC certification or other healthcare IT certifications.
    • May be too complex or costly for small independent practices.

    Foundation Medicine

    Offers genomic profiling and data solutions for oncology.

    Flatiron Health

    Provides oncology-specific EHR and real-world data analytics.

    Compare Tempus vs Flatiron Health →

    Guardant Health

    Specializes in liquid biopsy genomic testing for cancer.

    Explore EHR Software Ecosystem: Integrations, Partners & Add-Ons Compare Tempus with other Cardiology and Oncology EHR vendors or browse the full EHR & Healthcare Technology Solutions Index.

    Are you Tempus? Claim your vendor profile, add product details, and reach practices researching EHRs. Claim Profile/Get Listed

    Spotted an error? We publish this data as-is from CMS sources. If a practice or vendor listing is wrong, email support@ehratlas.com and we'll review it.

    About This Data & Methodology

    Source: This profile is assembled from the vendor's public website (features, capabilities, customer stories, media, and product updates) and EHRAtlas analyst evaluation. Compliance claims, pricing, and integration details should be verified directly with the vendor before making a purchase decision.

    Methodology: Where available, we extract structured facts (customers, outcomes, integrations, security certifications) directly from the vendor's own published pages. Claims are linked to their source. Scores reflect analyst judgment based on available public evidence and are not endorsements.

    Updates: Vendors are re-scanned periodically. Profile last reviewed on the date shown in the hero.

    Corrections: If you spot an error or a change in the vendor's product, capabilities, or pricing, email us and we'll review it.

    Spotted an error or need to submit a correction? Email support@ehratlas.com.

    ✨ EHR Matchmaker Visit Tempus ↗ For vendors: Claim profile →